120 related articles for article (PubMed ID: 36441800)
1. Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.
Hallett RM; Bonfill-Teixidor E; Iurlaro R; Arias A; Raman S; Bayliss P; Egorova O; Neva-Alejo A; McGray AR; Lau E; Bosch A; Beilschmidt M; Maetzel D; Fransson J; Huber-Ruano I; Anido J; Julien JP; Giblin P; Seoane J
Clin Cancer Res; 2023 Feb; 29(4):791-804. PubMed ID: 36441800
[TBL] [Abstract][Full Text] [Related]
2. Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors.
Borazanci E; Schram AM; Garralda E; Brana I; Vieito Villar M; Spreafico A; Oliva M; Lakhani NJ; Hoffman K; Hallett RM; Maetzel D; Hua F; Hilbert J; Giblin P; Anido J; Kelly A; Vickers PJ; Wasserman R; Seoane J; Siu LL; Hyman DM; Hoff DV; Tabernero J
ESMO Open; 2022 Aug; 7(4):100530. PubMed ID: 35921760
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
Metz S; Naeth G; Heinrich PC; Müller-Newen G
J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
[TBL] [Abstract][Full Text] [Related]
5. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
[TBL] [Abstract][Full Text] [Related]
6. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8
Pascual-García M; Bonfill-Teixidor E; Planas-Rigol E; Rubio-Perez C; Iurlaro R; Arias A; Cuartas I; Sala-Hojman A; Escudero L; Martínez-Ricarte F; Huber-Ruano I; Nuciforo P; Pedrosa L; Marques C; Braña I; Garralda E; Vieito M; Squatrito M; Pineda E; Graus F; Espejo C; Sahuquillo J; Tabernero J; Seoane J
Nat Commun; 2019 Jun; 10(1):2416. PubMed ID: 31186412
[TBL] [Abstract][Full Text] [Related]
7. Myeloid cell-mediated targeting of LIF to dystrophic muscle causes transient increases in muscle fiber lesions by disrupting the recruitment and dispersion of macrophages in muscle.
Flores I; Welc SS; Wehling-Henricks M; Tidball JG
Hum Mol Genet; 2021 Dec; 31(2):189-206. PubMed ID: 34392367
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.
Duluc D; Delneste Y; Tan F; Moles MP; Grimaud L; Lenoir J; Preisser L; Anegon I; Catala L; Ifrah N; Descamps P; Gamelin E; Gascan H; Hebbar M; Jeannin P
Blood; 2007 Dec; 110(13):4319-30. PubMed ID: 17848619
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
10. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.
Xu G; Wang H; Li W; Xue Z; Luo Q
J Cell Physiol; 2019 Apr; 234(4):3613-3620. PubMed ID: 30565675
[TBL] [Abstract][Full Text] [Related]
12. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
Wang MT; Fer N; Galeas J; Collisson EA; Kim SE; Sharib J; McCormick F
Nat Commun; 2019 Jul; 10(1):3055. PubMed ID: 31296870
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ.
Jeannin P; Duluc D; Delneste Y
Immunotherapy; 2011 Apr; 3(4 Suppl):23-6. PubMed ID: 21524164
[TBL] [Abstract][Full Text] [Related]
15. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
16. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.
Huyton T; Zhang JG; Luo CS; Lou MZ; Hilton DJ; Nicola NA; Garrett TP
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12737-42. PubMed ID: 17652170
[TBL] [Abstract][Full Text] [Related]
17. An anti-inflammatory role for leukemia inhibitory factor receptor signaling in regenerating skeletal muscle.
Hunt LC; Upadhyay A; Jazayeri JA; Tudor EM; White JD
Histochem Cell Biol; 2013 Jan; 139(1):13-34. PubMed ID: 22926285
[TBL] [Abstract][Full Text] [Related]
18. Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse.
Ghanei Z; Mehri N; Jamshidizad A; Joupari MD; Shamsara M
Sci Rep; 2020 Jul; 10(1):11465. PubMed ID: 32651426
[TBL] [Abstract][Full Text] [Related]
19. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
[TBL] [Abstract][Full Text] [Related]
20. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.
Quaglino A; Schere-Levy C; Romorini L; Meiss RP; Kordon EC
Breast Cancer Res; 2007; 9(5):R69. PubMed ID: 17925034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
